41.8 F
New York
Thursday, January 21, 2021

Trump Receives Gilead’s [NASDAQ: GILD] Remdesivir As Treatment For COVID-19 Infection

Must read

Haemonetics [NYSE: HAE] To Purchase Cardiva For An Upfront Payment Of $475M

Haemonetics Corporation revealed that the company has inked a definitive contract to purchase Cardiva Medical Inc. Under the contract, Haemontics will pay an...

Philips [NYSE: PHG] To Purchase Capsule Technologies For Cash Consideration Of USD 635M

Koninklijke Philip revealed that the company has inked a contract to purchase Capsule technologies. The company will pay a cash price of $636...

Thermo Fisher Scientific [NYSE: TMO] To Purchase Mesa Biotech For Approx. $450M In Cash

Thermo fisher scientific inc revealed that the company has signed a definitive contract to purchase Mesa Biotech. Thermo will pay a value price...

Shutterstock [NYSE: SSTK] To Extend Its Agreement With EPA

Shutterstock reported that the company renewed its exclusive contract with the European Pressphoto Agency. The extended contract is to distribute the visual content...

Gilead Sciences, Inc’s [NASDAQ: GILD] remdesivir has been given to President Donald Trump at Walter Reed National Military Medical Center on Friday.

It has been revealed that the white house doctors have recommended the experimental drug of Gilead to treat the COVID-19 infection of President Donald Trump.

White House Physician Sean Conley has released an update on the health of President Donald Trump. Sean Conley disclosed that President Trump is doing well and he doesn’t require any supplemental oxygen.

But the doctors have chosen the Gilead Sciences’ remdesivir to treat his COVID-19 infection. Trump has received the first dose and he is resting comfortably.

Shares of Gilead Sciences [NASDAQ: GILD] traded down 1.82% as it lost -1.15 during the trading session of Friday. It has a closing price of $62.17. GILD had a trading volume of 7.76 million as compared to the average volume of 8.70 million.

In the past 52-weeks of trading, this company’s share fluctuated between the low range of $60.89 and a high range of $85.97. GILD has moved up 2.10% from its 52-weeks low and moved down -27.68% from its 52-weeks high.

Looking at its profitability, this company has a current ratio of $2.30. GILD market capitalization has remained high, hitting $77.94 billion at the time of writing.

Gilead has committed to combat the spread of coronavirus by increasing the production of antiviral drug remdesivir.

The company has donated 1.5 million vials of Veklury (remdesivir) and provided clinical drug supply at no cost for evaluation as an investigational agent in clinical trials around the world. 

President Donald Trump has revealed on Friday that he and his wife Melania Trump has contracted coronavirus. Trump administration has earlier gave an emergency use authorization to Gilead’s remdesivir after it showed the positive results in treating COVID-19 patients.

More articles

Latest article

Tencent Music [NYSE: TME] To Purchase 100% Equity Interest Of Lazy Audio

Tencent Music Entertainment Group reported that the company has signed a contract to purchase 100 percent shares of Lazy Audio. Lazy audio is...

Desktop Metal [NYSE: DM] Inks Agreement To Purchase EnvisionTEC

Desktop Metal reported that the company inked a definitive contract to purchase EnvisionTEC. Desktop Metal will purchase EnvisionTEC for a total consideration of...

Sequential Brands [NASDAQ: SQBG] Partnered With Omega Apparel To Create A New Collection

Sequential Brands Group reported that the company has collaborated with Omega Apparel for its denim business. With this partnership, the company will develop...

Marathon Petroleum [NYSE: MPC] Appoints New CFO

Marathon Petroleum Corp. reported that the company has named Maryann T. Mannen as the CFO and Executive V.P of the company. Maryann has...

QUALCOMM [NASDAQ: QCOM] Announces To Purchase NUVIA For $1.4Billion

QUALCOMM Incorporated reported that its unit, Qualcomm technologies inked a contract to purchase NUVIA.  The company will purchase NUVIA for nearly $1.4B. The...

Trivago [NASDAQ: TRVG] Reported The Purchase Of Weekend.com

Trivago reported that the company has purchased Weekend.com. Weekend it just started based in Germany, its main aim is to provide stimulating getaway...

Arthur J. Gallagher [NYSE: AJG] Reports To Purchase 100% of The Bollington Wilson Group

Arthur J. Gallagher reported that the company has inked a contract to buy 100% of the Bollington Wilson group. Bollington is an insurance...

Grainger [NYSE: GWW] Reports Changes In The Executive Leadership

Grainger reported changes in its Executive leadership. The leading supplier and distributor of MRO products appointed Deidra Merriwether as the Chief Financial officer....